vs
爱德华生命科学（EW）与罗致恒富（RHI）财务数据对比。点击上方公司名可切换其他公司
爱德华生命科学的季度营收约是罗致恒富的1.3倍（$1.6B vs $1.3B），爱德华生命科学同比增速更快（16.7% vs -5.8%），过去两年爱德华生命科学的营收复合增速更高（9.7% vs -6.1%）
爱德华生命科学是总部位于美国加利福尼亚州尔湾的医疗科技企业，专注于人工心脏瓣膜及血流动力学监测领域，其研发的Sapien经导管主动脉心脏瓣膜采用牛组织材质，搭配球囊扩张式钴铬合金支架，可通过导管完成植入。
罗致恒富是1948年成立的国际人力资源咨询机构，总部位于加利福尼亚州门洛帕克和圣拉蒙，是全球规模领先的会计与金融领域人才派遣服务商之一，在全球范围内设有超过345个办公点。
EW vs RHI — 直观对比
营收规模更大
EW
是对方的1.3倍
$1.3B
营收增速更快
EW
高出22.5%
-5.8%
两年增速更快
EW
近两年复合增速
-6.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.6B | $1.3B |
| 净利润 | $380.7M | — |
| 毛利率 | 78.0% | 37.6% |
| 营业利润率 | 1.8% | 1.7% |
| 净利率 | 23.1% | — |
| 营收同比 | 16.7% | -5.8% |
| 净利润同比 | 6.8% | — |
| 每股收益（稀释后） | $0.66 | $0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EWRHI
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | $1.3B | ||
| Q3 25 | $1.6B | $1.4B | ||
| Q2 25 | $1.5B | $1.4B | ||
| Q1 25 | $1.4B | $1.4B | ||
| Q4 24 | $1.4B | $1.4B | ||
| Q3 24 | $1.4B | $1.5B | ||
| Q2 24 | $1.4B | $1.5B |
净利润EWRHI
| Q1 26 | $380.7M | — | ||
| Q4 25 | $91.2M | — | ||
| Q3 25 | $291.1M | $42.9M | ||
| Q2 25 | $333.2M | $41.0M | ||
| Q1 25 | $358.0M | $17.4M | ||
| Q4 24 | $385.6M | — | ||
| Q3 24 | $3.1B | $65.5M | ||
| Q2 24 | $366.3M | $68.2M |
毛利率EWRHI
| Q1 26 | 78.0% | — | ||
| Q4 25 | 78.1% | 37.6% | ||
| Q3 25 | 77.8% | 37.2% | ||
| Q2 25 | 77.5% | 37.2% | ||
| Q1 25 | 78.7% | 36.9% | ||
| Q4 24 | 78.9% | 38.8% | ||
| Q3 24 | 80.6% | 39.0% | ||
| Q2 24 | 79.9% | 39.2% |
营业利润率EWRHI
| Q1 26 | 1.8% | — | ||
| Q4 25 | 9.6% | 1.7% | ||
| Q3 25 | 19.8% | 1.0% | ||
| Q2 25 | 26.8% | 0.1% | ||
| Q1 25 | 27.9% | 2.9% | ||
| Q4 24 | 22.6% | 4.7% | ||
| Q3 24 | 25.9% | 4.1% | ||
| Q2 24 | 26.8% | 5.1% |
净利率EWRHI
| Q1 26 | 23.1% | — | ||
| Q4 25 | 5.8% | — | ||
| Q3 25 | 18.7% | 3.2% | ||
| Q2 25 | 21.7% | 3.0% | ||
| Q1 25 | 25.3% | 1.3% | ||
| Q4 24 | 27.8% | — | ||
| Q3 24 | 226.7% | 4.5% | ||
| Q2 24 | 26.7% | 4.6% |
每股收益（稀释后）EWRHI
| Q1 26 | $0.66 | — | ||
| Q4 25 | $0.16 | $0.32 | ||
| Q3 25 | $0.50 | $0.43 | ||
| Q2 25 | $0.56 | $0.41 | ||
| Q1 25 | $0.61 | $0.17 | ||
| Q4 24 | $0.65 | $0.53 | ||
| Q3 24 | $5.13 | $0.64 | ||
| Q2 24 | $0.61 | $0.66 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $464.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $1.3B |
| 总资产 | — | $2.9B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资EWRHI
| Q1 26 | — | — | ||
| Q4 25 | $4.2B | $464.4M | ||
| Q3 25 | $3.8B | $365.3M | ||
| Q2 25 | $4.1B | $380.5M | ||
| Q1 25 | $3.9B | $342.5M | ||
| Q4 24 | $4.0B | $537.6M | ||
| Q3 24 | $4.4B | $570.5M | ||
| Q2 24 | $2.0B | $547.4M |
股东权益EWRHI
| Q1 26 | — | — | ||
| Q4 25 | $10.3B | $1.3B | ||
| Q3 25 | $10.2B | $1.3B | ||
| Q2 25 | $10.5B | $1.3B | ||
| Q1 25 | $10.1B | $1.3B | ||
| Q4 24 | $10.0B | $1.4B | ||
| Q3 24 | $9.5B | $1.5B | ||
| Q2 24 | $7.4B | $1.5B |
总资产EWRHI
| Q1 26 | — | — | ||
| Q4 25 | $13.7B | $2.9B | ||
| Q3 25 | $13.3B | $2.8B | ||
| Q2 25 | $13.5B | $2.8B | ||
| Q1 25 | $13.0B | $2.7B | ||
| Q4 24 | $13.1B | $2.9B | ||
| Q3 24 | $13.0B | $3.0B | ||
| Q2 24 | $10.1B | $2.9B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $182.5M |
| 自由现金流经营现金流 - 资本支出 | — | $170.8M |
| 自由现金流率自由现金流/营收 | — | 13.1% |
| 资本支出强度资本支出/营收 | — | 0.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $266.8M |
8季度趋势，按日历期对齐
经营现金流EWRHI
| Q1 26 | — | — | ||
| Q4 25 | $450.9M | $182.5M | ||
| Q3 25 | $573.7M | $77.4M | ||
| Q2 25 | $290.2M | $119.4M | ||
| Q1 25 | $280.4M | $-59.3M | ||
| Q4 24 | $-127.5M | $154.8M | ||
| Q3 24 | $351.8M | $129.6M | ||
| Q2 24 | $371.5M | $142.0M |
自由现金流EWRHI
| Q1 26 | — | — | ||
| Q4 25 | $353.5M | $170.8M | ||
| Q3 25 | $516.2M | $63.6M | ||
| Q2 25 | $240.9M | $104.2M | ||
| Q1 25 | $224.4M | $-71.7M | ||
| Q4 24 | $-177.3M | $140.5M | ||
| Q3 24 | $299.9M | $111.8M | ||
| Q2 24 | $286.1M | $129.6M |
自由现金流率EWRHI
| Q1 26 | — | — | ||
| Q4 25 | 22.5% | 13.1% | ||
| Q3 25 | 33.2% | 4.7% | ||
| Q2 25 | 15.7% | 7.6% | ||
| Q1 25 | 15.9% | -5.3% | ||
| Q4 24 | -12.8% | 10.2% | ||
| Q3 24 | 22.1% | 7.6% | ||
| Q2 24 | 20.9% | 8.8% |
资本支出强度EWRHI
| Q1 26 | — | — | ||
| Q4 25 | 6.2% | 0.9% | ||
| Q3 25 | 3.7% | 1.0% | ||
| Q2 25 | 3.2% | 1.1% | ||
| Q1 25 | 4.0% | 0.9% | ||
| Q4 24 | 3.6% | 1.0% | ||
| Q3 24 | 3.8% | 1.2% | ||
| Q2 24 | 6.2% | 0.8% |
现金转化率EWRHI
| Q1 26 | — | — | ||
| Q4 25 | 4.94× | — | ||
| Q3 25 | 1.97× | 1.80× | ||
| Q2 25 | 0.87× | 2.91× | ||
| Q1 25 | 0.78× | -3.42× | ||
| Q4 24 | -0.33× | — | ||
| Q3 24 | 0.11× | 1.98× | ||
| Q2 24 | 1.01× | 2.08× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EW
暂无分部数据
RHI
| Finance And Accounting | $535.2M | 41% |
| Protiviti | $479.0M | 37% |
| Technology | $156.4M | 12% |
| Permanent Placement Talent Solutions | $102.6M | 8% |
| Other | $29.2M | 2% |
